Health Care SPDR (ETF) Company Profile (NYSE:XLV)

About Health Care SPDR (ETF)

Health Care SPDR (ETF) logoHealth Care Select Sector SPDR Fund (the Fund) seeks to closely match the returns and characteristics of the S&P Health Care Select Sector Index (the Index). The companies included in the Index are selected on the basis of general industry classification from a universe of companies defined by the Standard & Poor's 500 Composite Stock Index (S&P 500). The Health Care Select Sector Index includes companies from the industries, such as pharmaceuticals, healthcare providers and services, healthcare equipment and supplies, biotechnology, life sciences tools and services, and healthcare technology. Under normal market conditions, the Fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index. State Street Global Advisors acts as the Fund's investment manager.

Industry, Sector and Symbol:
  • Sector: Finance
  • Industry: Exchange Traded Fund
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: XLV
  • CUSIP:
Key Metrics:
  • Previous Close: $72.26
  • 50 Day Moving Average: $73.22
  • 200 Day Moving Average: $71.60
  • 52-Week Range: $62.68 - $76.00
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $N/A
Additional Links:
Companies Related to Health Care SPDR (ETF):

Analyst Ratings

Consensus Ratings for Health Care SPDR (ETF) (NYSE:XLV) (?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: N/A

Analysts' Ratings History for Health Care SPDR (ETF) (NYSE:XLV)
Show:
DateFirmActionRatingPrice TargetDetails
2/9/2016AltaCorp CapitalReiterated RatingNeutralView Rating Details
10/7/2014Morgan StanleyDowngradeUnderweightView Rating Details
(Data available from 9/28/2014 forward)

Earnings

Earnings History for Health Care SPDR (ETF) (NYSE:XLV)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Health Care SPDR (ETF) (NYSE:XLV)
Current Year EPS Consensus Estimate: $1.58 EPS

Dividends

Current Dividend Information for Health Care SPDR (ETF) (NYSE:XLV)
Annual Dividend:$1.14
Dividend Yield:1.57%
Dividend Growth:21.00% (3 Year Average)
Payout Ratio:72.15% (Based on Current Year Consensus EPS Estimate)

Dividend History for Health Care SPDR (ETF) (NYSE:XLV)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/19/2015quarterly$0.261.38%6/19/20156/23/20156/29/2015
3/20/2015quarterly$0.211.11%3/20/20153/24/20153/30/2015
12/19/2014quarterly$0.261.48%12/19/201412/23/201412/30/2014
9/19/2014quarterly$0.231.42%9/19/20149/23/20149/29/2014
6/20/2014quarterly$0.231.49%6/20/20146/24/20146/30/2014
3/21/2014quarterly$0.201.41%3/21/20143/25/20143/31/2014
12/20/2013quarterly$0.231.64%12/20/201312/24/201312/31/2013
9/20/2013quarterly$0.211.65%9/20/20139/24/20139/30/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Health Care SPDR (ETF) (NYSE:XLV)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Health Care SPDR (ETF) (NYSE:XLV)
DateHeadline
marketrealist.com logoIs Kalydeco Positioned Well Enough to Achieve Sustained Growth ... - Market Realist (NYSE:XLV)
marketrealist.com - September 28 at 5:55 AM
nasdaq.com logoXLV, AMGN, MDT, GILD: ETF Inflow Alert - Nasdaq (NYSE:XLV)
www.nasdaq.com - September 28 at 5:55 AM
News IconExpect More Volatility for Healthcare ETFs (NYSE:XLV)
www.etftrends.com - September 27 at 8:04 PM
thestreet.com logoWall Street Sells Off on Worries Over Clinton-Trump Showdown - TheStreet.com (NYSE:XLV)
www.thestreet.com - September 27 at 8:17 AM
marketrealist.com logoIs Kalydeco Positioned Well Enough to Achieve Sustained Growth? (NYSE:XLV)
marketrealist.com - September 27 at 8:16 AM
marketrealist.com logoHigher Discontinuations Are among Orkambi's Concerns - Market Realist (NYSE:XLV)
marketrealist.com - September 26 at 8:10 PM
thestreet.com logoStocks Fall as Health Care Slumps Ahead of Presidential Debate - TheStreet.com (NYSE:XLV)
www.thestreet.com - September 26 at 8:10 PM
marketrealist.com logoJohnson & Johnson Gets FDA Approval for Type 2 Diabetes Drug - Market Realist (NYSE:XLV)
marketrealist.com - September 24 at 5:54 AM
marketrealist.com logoHow’s Gilead Sciences Expected to Perform in 2016? (NYSE:XLV)
marketrealist.com - September 23 at 7:31 PM
forbes.com logoMonday Sector Laggards: Healthcare, Services - Forbes (NYSE:XLV)
www.forbes.com - September 20 at 8:02 AM
nasdaq.com logoMid-Day ETF Update: ETFs, Stocks Firmer as Crude Oil Prices Rise; Investors Optimistic Ahead of FOMC Meeting (NYSE:XLV)
www.nasdaq.com - September 19 at 3:16 PM
forbes.com logoMonday Sector Laggards: Healthcare, Services (NYSE:XLV)
www.forbes.com - September 19 at 3:16 PM
marketrealist.com logoAnalyzing St. Jude Medical's Latest Dividend Payment - Market Realist (NYSE:XLV)
marketrealist.com - September 16 at 7:51 PM
marketrealist.com logoThis Advisory Firm’s Name Held True to Form for St. Jude Medical (NYSE:XLV)
marketrealist.com - September 16 at 7:51 PM
blogs.barrons.com logoThe Case for Health Care Stocks (Especially Biotech) - Barron's (blog) (NYSE:XLV)
blogs.barrons.com - September 15 at 8:19 PM
finance.yahoo.com logoPrice of pharma innovation: Pro (NYSE:XLV)
finance.yahoo.com - September 15 at 11:59 AM
blogs.barrons.com logoThe Case for Health Care Stocks (Especially Biotech) (NYSE:XLV)
blogs.barrons.com - September 15 at 11:59 AM
News IconYear-Over-Year Gains Prevail For US Sector ETFs (NYSE:XLV)
www.capitalspectator.com - September 14 at 12:36 PM
News IconHow Will Healthcare Stocks Be Affected If Trump Wins? - Dividend.com (NYSE:XLV)
www.dividend.com - September 13 at 5:46 AM
marketwatch.com logoPerrigo's stock surges after Starboard discloses stake (NYSE:XLV)
www.marketwatch.com - September 12 at 7:38 PM
nasdaq.com logoXLV Crowded With Sellers - Nasdaq (NYSE:XLV)
www.nasdaq.com - September 10 at 5:45 AM
marketrealist.com logoPfizer's Efforts to Revive Its Essential Health Business PART 1 OF 4 - Market Realist (NYSE:XLV)
marketrealist.com - September 10 at 5:45 AM
marketrealist.com logoRubenstein Thinks That Healthcare Spending Will Increase in the US - Market Realist (NYSE:XLV)
marketrealist.com - September 10 at 5:45 AM
nasdaq.com logoXLV Crowded With Sellers (NYSE:XLV)
www.nasdaq.com - September 9 at 7:48 PM
nasdaq.com logoETF Preview: ETFs Tick Lower, Stocks Mixed as ECB Keeps Interest Rates Steady; Crude Oil Rise on China Demand ... - Nasdaq (NYSE:XLV)
www.nasdaq.com - September 8 at 12:07 PM
marketrealist.com logoWhy Leon Cooperman Thinks Interest Rate Normalization Is Required (NYSE:XLV)
marketrealist.com - September 8 at 12:07 PM
marketrealist.com logoHow Cepheid Fits Strategically into DHR’s Portfolio (NYSE:XLV)
marketrealist.com - September 7 at 8:17 PM
marketrealist.com logoThis Celgene Cancer Treatment Could Lead the Industry by 2021 - Market Realist (NYSE:XLV)
marketrealist.com - September 7 at 12:05 PM
News IconHealthcare Stocks Lag Market On Drug Pricing (NYSE:XLV)
www.talkmarkets.com - September 2 at 8:01 PM
News IconHealthcare ETFs Need Some Rest (NYSE:XLV)
www.etftrends.com - September 2 at 8:01 PM
etfdailynews.com logoOptions Activity Shows Traders are Betting on a Recovery for This Health Care ETF (NYSE:XLV)
etfdailynews.com - September 2 at 8:01 PM
etfdailynews.com logoOptions Activity Shows Traders are Betting on a Recovery for This Health Care ETF - ETF Daily News (NYSE:XLV)
etfdailynews.com - September 1 at 11:34 AM
marketrealist.com logoAn Overview of Pfizer's Oncology Business - Market Realist - Market Realist (NYSE:XLV)
marketrealist.com - August 31 at 5:49 AM
marketrealist.com logoA Look at Pfizer's Innovative Health Business - Market Realist (NYSE:XLV)
marketrealist.com - August 31 at 5:49 AM
benzinga.com logoBrian Stutland Sees Unusual Options Activity In The Healthcare ETF - Benzinga (NYSE:XLV)
www.benzinga.com - August 31 at 5:49 AM
nasdaq.com logoXLV, IELG: Big ETF Outflows (NYSE:XLV)
www.nasdaq.com - August 30 at 11:38 AM
forbes.com logoXLV: Big ETF Outflows (NYSE:XLV)
www.forbes.com - August 30 at 11:38 AM
finance.yahoo.com logoBig trader doubles down on health care (NYSE:XLV)
finance.yahoo.com - August 30 at 11:38 AM
marketrealist.com logoA Look at Allergan's Growth Pharma Model - Market Realist (NYSE:XLV)
marketrealist.com - August 29 at 8:17 PM
barrons.com logoHealthcare Stocks Are Looking Sick, Charts Say - Barron's (NYSE:XLV)
www.barrons.com - August 29 at 8:17 PM
finance.yahoo.com logoEpiPen as metaphor for broken health care system: Brill (NYSE:XLV)
finance.yahoo.com - August 29 at 8:17 PM
finance.yahoo.com logoUS health care system needs more transparency: Pro (NYSE:XLV)
finance.yahoo.com - August 29 at 8:17 PM
insidermonkey.com logoHuge Jumps In Hedge Fund Popularity For These 5 Healthcare Stocks - Insider Monkey (blog) (NYSE:XLV)
www.insidermonkey.com - August 27 at 5:31 AM
nasdaq.com logoHealth Care Sector Update for 08/26/2016: XLV, JNJ, PFE, ABT, MRK, AMGN, QURE, HLF, ABC, WBA - Nasdaq (NYSE:XLV)
www.nasdaq.com - August 26 at 11:13 AM
marketwatch.com logoMylan stock set to snap four-day losing streak - MarketWatch (NYSE:XLV)
www.marketwatch.com - August 25 at 8:36 PM
thestreet.com logoCrude Oil, Health Care Team Up to Pull Wall Street Lower - TheStreet - TheStreet.com (NYSE:XLV)
www.thestreet.com - August 25 at 5:32 AM
finance.yahoo.com logoAn Appealing, Cost-Efficient Healthcare ETF (NYSE:XLV)
finance.yahoo.com - August 24 at 8:07 PM
investopedia.com logoReturn Analysis: Health Care Select Sector SPDR (XLV) (NYSE:XLV)
www.investopedia.com - August 24 at 8:07 PM
investopedia.com logoReturn Analysis: Health Care Select Sector SPDR (XLV) - Investopedia (NYSE:XLV)
www.investopedia.com - August 24 at 11:26 AM
marketrealist.com logoHow AbbVie Expects Risankizumab to Be a Transformative Therapy - Market Realist (NYSE:XLV)
marketrealist.com - August 23 at 8:29 PM

Social

Health Care SPDR (ETF) (NYSE:XLV) Chart for Wednesday, September, 28, 2016


Last Updated on 9/28/2016 by MarketBeat.com Staff